Page last updated: 2024-08-24

iobitridol and Hypertension

iobitridol has been researched along with Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azizi, M; Bobrie, G; Curis, E; Frank, M; Monge, M; Okada, T; Pellerin, O; Plouin, PF; Sapoval, M; Savard, S; Sugimoto, K; Yamaguchi, M1
Jang, GC; Jung, JW; Kang, HR; Kim, GW; Kim, MY; Kim, S; Kim, SH; Nam, YH; Park, HJ; Park, HK; Park, JS; Park, JW; Yang, MS1
Hammerstingl, R; Honold, E; Mohajeri, H; Vogl, TJ; Wolf, M1

Other Studies

3 other study(ies) available for iobitridol and Hypertension

ArticleYear
Eligibility for renal denervation: anatomical classification and results in essential resistant hypertension.
    Cardiovascular and interventional radiology, 2015, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Denervation; Drug Resistance; Essential Hypertension; Female; Humans; Hypertension; Iohexol; Male; Middle Aged; Observer Variation; Radiographic Image Enhancement; Renal Artery; Reproducibility of Results; Tomography, X-Ray Computed; Young Adult

2015
Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study.
    European radiology, 2017, Volume: 27, Issue:7

    Topics: Blood Pressure; Cohort Studies; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Iohexol; Male; Middle Aged; Osmolar Concentration; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index

2017
Safety of iobitridol in the general population and at-risk patients.
    European radiology, 2006, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asthma; Body Mass Index; Child; Child, Preschool; Contrast Media; Coronary Disease; Diabetes Complications; Female; Humans; Hypersensitivity; Hypertension; Hypotension; Iohexol; Male; Middle Aged; Premedication; Product Surveillance, Postmarketing; Risk Factors; Safety; Sex Factors

2006